ZOLBETUXIMAB

1525 reported adverse events

Drug classes: Claudin 18.2-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking ZOLBETUXIMAB:

# Side effect Count
0 NAUSEA 558
1 VOMITING 271
2 DECREASED APPETITE 201
3 ASCITES 138
4 HYPOALBUMINAEMIA 129
5 MALIGNANT NEOPLASM PROGRESSION 117
6 BLOOD ALBUMIN DECREASED 100
7 DIARRHOEA 82
8 OEDEMA PERIPHERAL 67
9 MYELOSUPPRESSION 66
See all common reactions for ZOLBETUXIMAB

ZOLBETUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADENOCARCINOMA GASTRIC RECURRENT 2 0.6667
1 METASTASES TO PERINEUM 3 0.2727
2 OESOPHAGOGASTROSCOPY ABNORMAL 1 0.1667
3 INSTILLATION SITE HYPOAESTHESIA 1 0.1429
4 RED CELL DISTRIBUTION WIDTH 1 0.1000
5 PROTEIN-LOSING GASTROENTEROPATHY 25 0.0503
6 PORTAL VEIN EMBOLISM 1 0.0385
7 PREPYLORIC STENOSIS 1 0.0370
8 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 5 0.0338
9 GASTRITIS HYPERTROPHIC 1 0.0244
See all enriched reactions for ZOLBETUXIMAB